Delivery Order SPE2DB24D2018-SPE2DB24FWUR9

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,140.34 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The award covers the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, for the government. The contract has an ultimate completion date of June 25, 2024 and was awarded on June 24, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $3,203.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. The contract has an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a $4,379.76 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a respiratory medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
This is a $2,082.64 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, and has a completion date of June 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a $10,351.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The order has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military...
This is a $3,544.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription medication. It has an ultimate completion date of May 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical,...
This is a $6,622.70 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a period of performance through September 17, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for delivering a wide range of medical commodities to support military healthcare programs. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,454.81 contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a respiratory medication, with a period of performance through January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a $8,654.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for ADVAIR HFA 115-21 MCG INHALER 12GM and has an ultimate completion date of December 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,876.81 order is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a specialty pharmaceutical product. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB24FWUR9
    Delivery Order

This is a $3,908.22 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This contract supports the DLA's role in providing pharmaceutical and medical supplies to military treatment facilities and other government healthcare programs. The award has no set-aside designation, and the ultimate completion date is September 27, 2024.

Generated 12/26/24, 9:01 AM